Hepa 1-6 In Vitro LDH Assay (Cell Viability)

CAT#: ITS-1022-YF2320
Target Cell Organism: Mouse
Target Cell Alternative Name: Hepa1-6
Target Cell Name: Hepa 1-6
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide Hepa 1-6-based In Vitro LDH Assay (Cell Viability) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Hepa 1-6
Target Cell Organism
Mouse
Target Cell Background
The Hepa 1-6 tumorigenic epithelial cell line is derived from liver cells of the BW7756 mouse (Mus musculus) with hepatoma. Hepa 1-6 has been negatively tested for mousepox and is widely used in mammalian liver tissue functions research.
Target Cell Alternative Name
Hepa1-6
Related Diseases
Liver Hepatoma
Research Area
Oncology
Assay Name
In Vitro LDH Assay (Cell Viability)
Short Description
Hepa 1-6-cell based In Vitro LDH Assay (Cell Viability)
Assay Description
Lactate dehydrogenase leakage assay (LDH assay) can also be used to determine viability of cancer cells. Upon treatment with a testing drug, if the drug can rupture the cell membrane, cells release LDH to the culture medium and released LDH can be quantified.
Assay Alternative Names
Lactate Dehydrogenase Leakage Assay
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Viability Assay
Assay MOA
Cell-based Viability Assays Based on Cellular Enzymes and Proteins
For Research Use Only | Not For Clinical Use
Online Inquiry